SILICON LABORATORIES INC (SLAB)
US8269191024 - Common Stock
We assign a fundamental rating of 4 out of 10 to SLAB. SLAB was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for SLAB as it has an excellent financial health rating, but there are worries on the profitability. SLAB is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SLAB has reported negative net income.
In the past year SLAB has reported a negative cash flow from operations.
Of the past 5 years SLAB 4 years were profitable.
In multiple years SLAB reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -7.81%, SLAB is doing worse than 69.81% of the companies in the same industry.
SLAB's Return On Equity of -9.01% is on the low side compared to the rest of the industry. SLAB is outperformed by 67.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.81% | ||
| ROE | -9.01% | ||
| ROIC | N/A |
ROA(3y)24.47%
ROA(5y)15.04%
ROE(3y)33.12%
ROE(5y)20.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SLAB has a better Gross Margin (56.36%) than 76.42% of its industry peers.
In the last couple of years the Gross Margin of SLAB has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SLAB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 56.36% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y-0.39%
2. Health
2.1 Basic Checks
SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SLAB has been reduced compared to 1 year ago.
SLAB has less shares outstanding than it did 5 years ago.
SLAB has a better debt/assets ratio than last year.
2.2 Solvency
SLAB has an Altman-Z score of 15.85. This indicates that SLAB is financially healthy and has little risk of bankruptcy at the moment.
SLAB has a Altman-Z score of 15.85. This is amongst the best in the industry. SLAB outperforms 88.68% of its industry peers.
There is no outstanding debt for SLAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 15.85 |
ROIC/WACCN/A
WACC12.08%
2.3 Liquidity
A Current Ratio of 5.80 indicates that SLAB has no problem at all paying its short term obligations.
SLAB's Current ratio of 5.80 is amongst the best of the industry. SLAB outperforms 83.02% of its industry peers.
SLAB has a Quick Ratio of 4.02. This indicates that SLAB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.02, SLAB is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.8 | ||
| Quick Ratio | 4.02 |
3. Growth
3.1 Past
The earnings per share for SLAB have decreased strongly by -109.36% in the last year.
Measured over the past years, SLAB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.59% on average per year.
The Revenue for SLAB has decreased by -38.10% in the past year. This is quite bad
Measured over the past years, SLAB shows a decrease in Revenue. The Revenue has been decreasing by -2.07% on average per year.
EPS 1Y (TTM)-109.36%
EPS 3Y-19.07%
EPS 5Y-15.59%
EPS growth Q2Q-182.14%
Revenue 1Y (TTM)-38.1%
Revenue growth 3Y15.26%
Revenue growth 5Y-2.07%
Revenue growth Q2Q-56.89%
3.2 Future
SLAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.10% yearly.
The Revenue is expected to grow by 13.81% on average over the next years. This is quite good.
EPS Next Y-126.84%
EPS Next 2Y55.03%
EPS Next 3Y51.84%
EPS Next 5Y48.1%
Revenue Next Year-15.58%
Revenue Next 2Y10.99%
Revenue Next 3Y13.91%
Revenue Next 5Y13.81%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SLAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
SLAB is valuated quite expensively with a Price/Forward Earnings ratio of 34.33.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SLAB is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of SLAB to the average of the S&P500 Index (20.47), we can say SLAB is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 34.33 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SLAB's earnings are expected to grow with 51.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.03%
EPS Next 3Y51.84%
5. Dividend
5.1 Amount
No dividends for SLAB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SILICON LABORATORIES INC
NASDAQ:SLAB (5/17/2024, 10:00:36 AM)
131.19
+1 (+0.77%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.19B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 34.33 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.81% | ||
| ROE | -9.01% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 56.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.8 | ||
| Quick Ratio | 4.02 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-109.36%
EPS 3Y-19.07%
EPS 5Y
EPS growth Q2Q
EPS Next Y-126.84%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-38.1%
Revenue growth 3Y15.26%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y